Announced Thu, 21 May · 15:53 IST

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd. has ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Omkar Pharmachem Ltd has informed BSE that a meeting of its Board of Directors is scheduled for May 30, 2026 at 5:00 PM at the company's registered office. The meeting will consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. Additionally, the trading window for dealing in shares of the company will continue to remain closed till June 01, 2026 for all Designated Persons and their Immediate Relatives. This is a routine regulatory intimation under SEBI LODR Regulations.

Likely market impact

This is a standard board meeting notice for quarterly and annual results approval. The actual financial results and their implications for shareholders will be known only after the meeting is held and results are disclosed.